dihydrotetrabenazine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, L; Bessler, M; Durak, E; Freeby, MJ; Harris, P; Inabnet, WB; Korner, J; Lifante, JC; Milone, L; Sebastian, M | 1 |
| Alavi, A; Blomberg, BA; Eriksson, O; Saboury, B | 1 |
2 other study(ies) available for dihydrotetrabenazine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass.
Topics: Animals; Bariatric Surgery; Carbon Radioisotopes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Duodenum; Gastrectomy; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Homeostasis; Insulin; Insulin-Secreting Cells; Jejunum; Positron-Emission Tomography; Rats; Rats, Inbred Strains; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2010 |
β-Cell mass imaging with DTBZ positron emission tomography: is it possible?
Topics: Animals; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Insulin-Secreting Cells; Molecular Imaging; Pancreas; Positron-Emission Tomography; Rats; Tetrabenazine | 2013 |